GLP-1 & Obesity Drug Brand Directors Email List

2,392+ verified GLP-1 & Obesity Drug Brand Directors contacts. Start with verified baseline email & phone data, then layer optional buyer intent topics and facility technology intelligence to target in-market healthcare decision-makers with total precision.

2,392+ Contacts
October 2026 Verified
99% Accuracy

Real-Time HCP Data Engine

2,392+
Verified GLP-1 & Obesity Drug Brand Directors
MATCH RATE 98.4%
BUYING INTENT 20+ Topics
TECH INTEL Veeva CRM / IQVIA
GROWTH +12.5%
LIVE CONTACT, INTENT & TECH INTELLIGENCE FEED
ACTIVE VERIFICATION
SPECIALIST LOCATION BUYING INTENT STATUS
Dr. Alan Wright Dallas, TX EHR Migration VERIFIED
Dr. Lisa Ray Miami, FL AI Diagnostics VERIFIED
Dr. James Liu Seattle, WA Telehealth Platform VERIFIED
Dr. Robert Kahn Boston, MA Robotic Surgery VERIFIED

Request Your Free Custom Sample

Trusted by Leading Healthcare Organizations

100% Compliant & Secure Outreach

GDPR COMPLIANT
CCPA COMPLIANT
CAN-SPAM ACT COMPLIANT
GLP-1 & Obesity Drug Brand Directors list at a glance

The MedicalProspects GLP-1 & Obesity Drug Brand Directors Email List has 2,392 verified GLP-1 and obesity commercialization director contacts worldwide, updated October 2026: pharma and biotech leaders who launch and market GLP-1 and obesity therapies. Titles and employers are verified and emails are checked before delivery. Filter by function focus, organization type, seniority or location.

Scope

Who is in the GLP-1 & Obesity Drug Brand Directors Email List

Pharma and biotech leaders who launch and market GLP-1 and obesity therapies. They sit in pharmaceutical company, biotech company or telehealth partner.

The 2,392 figure counts people. Records can be filtered by brand strategy, market access or patient support programs. Related audiences are separate lists, including pharmaceutical sales representatives and obesity medicine specialists.

Titles

Director of Obesity Commercialization, Brand Director, GLP-1, VP of Market Access, Head of Patient Support Programs or Director of Field Strategy

Organization types

Pharmaceutical company, Biotech company, Telehealth partner, Specialty pharmacy or Agency

Geography

United States plus international GLP-1 and obesity commercialization directors; the 2,392 total covers both

Use cases

Who buys this list and why

Typical buyers of GLP-1 and obesity commercialization directors lists include market access and payer strategy, patient support and hub services or hcp engagement and media, and the right filters depend on function focus and organization type.

Market access and payer strategy

Access and analytics vendors reach commercialization leaders.

Patient support and hub services

Hub and adherence vendors reach directors.

HCP engagement and media

Agencies and HCP media reach brand leaders.

Supply and specialty distribution

Distributors reach commercialization teams.

See how many GLP-1 & Obesity Drug Brand Directors match your campaign

Tell us your filters and get counts plus 20 free sample records within 24 to 48 hours.

Data

Data fields in each GLP-1 and obesity commercialization director record

Each GLP-1 & Obesity Drug Brand Directors record includes the core fields below as standard. Intent signals and technology data are optional add-on layers on top.

Standard fields in every record 7 core fields
Name and titleFirst and last name and exact job title
SeniorityExecutive, director or manager level
OrganizationOrganization where the GLP-1 and obesity commercialization director works, its type and parent organization
Function focusBrand strategy, Market access, Patient support programs, Sales and field strategy or Digital and HCP marketing, where available
Organization profileSize and ownership, where available
Email and phoneProfessional email for each GLP-1 and obesity commercialization director, verified before delivery; office phone where available
AddressOrganization address of the GLP-1 and obesity commercialization director: city, state or region, postal code and country

Sample GLP-1 & Obesity Drug Brand Directors records (masked)

Layer 1: Verified records (standard) Layer 2: Intent signals (optional add-on) Layer 3: Technology data (optional add-on)
Drag or scroll horizontally to see all columns
NameTitleSeniorityOrganization typeFunction focusCity, StateEmailLevelIntent signal (add-on)Technology (add-on)Status
W**** S****Director of Obesity CommercializationDirectorPharmaceutical companyBrand strategyDenver, COw****@****.comSystem High (Clinical Trial Systems) Cardiology & Diagnostic SystemsVERIFIED
G**** C****Brand Director, GLP-1DirectorBiotech companyMarket accessCharlotte, NCg****@****.eduFacility High (AI Diagnostics) HST Pathways & RCM SuiteVERIFIED
P**** H****VP of Market AccessVPTelehealth partnerPatient support programsDallas, TXp****@****.orgFacility High (RCM Automation) Palo Alto Networks SecurityVERIFIED
C**** N****Head of Patient Support ProgramsDirectorSpecialty pharmacySales and field strategyAtlanta, GAc****@****.orgSystem Active (MedTech Procurement) Epic Systems / Cerner EHRVERIFIED
K**** W****Director of Field StrategyDirectorAgencyDigital and HCP marketingMinneapolis, MNk****@****.comFacility High (EHR Migration) Nuance & Viz.ai AI DiagnosticsVERIFIED

Names, emails, phones and NPIs are masked. Rows are illustrative, not real people.

Download the GLP-1 & Obesity Drug Brand Directors sample and structure

Get the masked file to review the field structure, or request a free custom sample with real contacts matching your filters.

NPI-matched (U.S. records)99% deliverability guaranteeCAN-SPAM compliant business data1:1 hard bounce replacement
Targeting

Filters that matter for GLP-1 and obesity commercialization director campaigns

You select GLP-1 and obesity commercialization directors by the attributes below.

Build your selection

Function focus

Brand strategy, Market access, Patient support programs, Sales and field strategy or Digital and HCP marketing.

Add to my brief

Organization type

Pharmaceutical company, Biotech company, Telehealth partner, Specialty pharmacy or Agency.

Add to my brief

Seniority

Executives approve; directors evaluate; managers run day-to-day for GLP-1 and obesity commercialization directors.

Add to my brief

Organization size

Select by how large the employer is and who owns it.

Add to my brief

Location

Limit GLP-1 and obesity commercialization directors to the regions you cover.

Add to my brief
Tap the filters you need and we will build a counts brief for you.
Intent Signal Configurator (Optional Add-on)

Which signals should I layer on the GLP-1 & Obesity Drug Brand Directors list?

Choose your offer to see the subjects GLP-1 and obesity commercialization directors look into when they weigh a new vendor.

Technology Intelligence Configurator (Optional Add-on)

Which software & facility equipment filters match your campaign?

Pick a technology focus and we'll show the installed-base filters that fit GLP-1 and obesity commercialization directors.

Ready to Activate Your Intent-Targeted Campaign?

Select a campaign type above, then request your custom intent-filtered segment. Our data team will share counts, pricing & a free sample within 24 hours.

CSV / Excel
API Ready
FAQ

GLP-1 & Obesity Drug Brand Directors list FAQs

How many GLP-1 and obesity commercialization directors are on the list?

The list has 2,392 verified GLP-1 and obesity commercialization director contacts in the U.S. and internationally, current as of October 2026, working in pharmaceutical company, biotech company or telehealth partner.

Can I select brand strategy separately from market access?

Yes. Choose brand strategy, market access or patient support programs under function focus, and request the sample to see the count for each.

How is this different from pharmaceutical sales representatives?

These are commercial leaders. Pharmaceutical sales representatives are field reps.

Can I reach obesity medicine specialists?
How are GLP-1 and obesity commercialization director records verified?

Titles and employers of each GLP-1 and obesity commercialization director are verified against organization sources and refreshed monthly, and emails are verified before every delivery.

Verification

How the data is verified and delivered

01

Titles and employers verified

Each GLP-1 & Obesity Drug Brand Directors record's title and employer are verified against organization sources and refreshed monthly, so the list tracks job changes rather than old titles.

02

Email checked every delivery

Emails for GLP-1 & Obesity Drug Brand Directors are verified before every delivery, with a 99% deliverability guarantee and 1:1 replacement of hard bounces.

03

Samples first, fast delivery

20 free sample records matched to your function focus and organization type filters before you buy. Delivered as CSV or Excel with name and title, seniority and organization. Usually within 24 to 48 hours.

04

Compliant business data

Professional business contact data for GLP-1 & Obesity Drug Brand Directors only, for CAN-SPAM compliant outreach. No patient data.

Want This Audience Customized? We Can Do That.

Share your non-negotiable filters and we'll deliver a campaign-ready file built for your exact use case.

Request Your List